Autopsy report · NCT04932031

Risk Prediction of Taxane Chemotherapy-Induced Peripheral Neuropathy

“under enrollment for primary endpoint analysis”

The sponsor’s own words in the registry.

Life of this trial

• Registered 11 months before it started.
• Ran for about 1 year 5 months before it stopped.
• 123 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Sponsor

Sapere Bio

Sponsor type

Industry

Conditions

Breast Cancer; Chemotherapy-induced Peripheral Neuropathy; Aging

Participants

123

Sites

2

Countries

United States

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.